<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2025-104-5-615-620</article-id><article-id custom-type="edn" pub-id-type="custom">xpghfp</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-4929</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ГИГИЕНА ПИТАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FOOD HYGIENE</subject></subj-group></article-categories><title-group><article-title>К вопросу гигиенического нормирования в пищевой продукции остаточных количеств антибактериальных препаратов ветеринарного назначения (систематический обзор)</article-title><trans-title-group xml:lang="en"><trans-title>On the issue of hygienic regulation of residual quantities of antibacterial drugs for veterinary use in food products (systematic review)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2356-1145</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайцева</surname><given-names>Нина Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Zaitseva</surname><given-names>Nina V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор мед. наук, профессор, академик РАН, научный руководитель ФБУН «ФНЦ МПТ УРЗН», 614045, Пермь, Россия</p><p>e-mail: znv@fcrisk.ru</p></bio><bio xml:lang="en"><p>DSc (Medicine), Professor, Academician of the RAS, Scientific Director of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation</p><p>e-mail: znv@fcrisk.ru</p></bio><email xlink:type="simple">znv@fcrisk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5171-3105</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шур</surname><given-names>Павел Залманович</given-names></name><name name-style="western" xml:lang="en"><surname>Shur</surname><given-names>Pavel Z.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор мед. наук, гл. науч. сотр., учёный секретарь ФБУН «ФНЦ МПТ УРЗН» Роспотребнадзора, 614045, Пермь, Россия</p><p>e-mail: shur@fcrisk.ru</p></bio><bio xml:lang="en"><p>DSc (Medicine), leading researcher, Secretary of the Academic Council, Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation</p><p>e-mail: shur@fcrisk.ru</p></bio><email xlink:type="simple">shur@fcrisk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0259-5509</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зеленкин</surname><given-names>Сергей Евгеньевич</given-names></name><name name-style="western" xml:lang="en"><surname>Zelenkin</surname><given-names>Sergey E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Науч. сотр. отд. анализа риска здоровью ФБУН «ФНЦ МПТ УРЗН» Роспотребнадзора, 614045, Пермь, Россия</p><p>e-mail: zelenkin@fcrisk.ru</p></bio><bio xml:lang="en"><p>Researcher of the Health risk analysis department, Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation</p><p>e-mail: zelenkin@fcrisk.ru</p></bio><email xlink:type="simple">zelenkin@fcrisk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3594-2650</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суворов</surname><given-names>Дмитрий Владимирович</given-names></name><name name-style="western" xml:lang="en"><surname>Suvorov</surname><given-names>Dmitrii V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Науч. сотр. отд. анализа риска здоровью ФБУН «ФНЦ МПТ УРЗН» Роспотребнадзора, 614045, Пермь, Россия</p><p>e-mail: suvorov@fcrisk.ru</p></bio><bio xml:lang="en"><p>Researcher of the Health risk analysis department, Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation</p><p>e-mail: suvorov@fcrisk.ru</p></bio><email xlink:type="simple">suvorov@fcrisk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения» Роспотребнадзора</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific Center for Medical and Preventive Health Risk Management Technologies</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>06</month><year>2025</year></pub-date><volume>104</volume><issue>5</issue><fpage>615</fpage><lpage>620</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Зайцева Н.В., Шур П.З., Зеленкин С.Е., Суворов Д.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Зайцева Н.В., Шур П.З., Зеленкин С.Е., Суворов Д.В.</copyright-holder><copyright-holder xml:lang="en">Zaitseva N.V., Shur P.Z., Zelenkin S.E., Suvorov D.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/4929">https://www.rjhas.ru/jour/article/view/4929</self-uri><abstract><p>Широкое использование в сельском хозяйстве и животноводстве антибактериальных ветеринарных препаратов приводит к накоплению их остатков в пищевых продуктах. Ключевым аспектом обеспечения безопасности пищевой продукции является гигиеническое нормирование остатков ветеринарных препаратов по критериям допустимого риска для здоровья. Антибактериальные препараты оказывают токсическое действие, нарушают микробиоту кишечника и способствуют формированию антибиотикорезистентности. Актуальным является системный обзор критериев установления допустимых суточных доз (ДСД) ветеринарных препаратов – основы для разработки максимально допустимых уровней их содержания в пище.</p><p>Цель исследования – анализ существующих методических подходов и критериев обоснования гигиенических нормативов остаточных количеств антибактериальных ветеринарных препаратов в пищевых продуктах.</p><p>Выполнен систематический обзор литературных источников (PRISMA) с оценкой подходов к установлению ДСД, рассматривающих токсикологические и микробиологические аспекты, а также формирование резистентных штаммов микроорганизмов. Для негативного действия ветеринарных препаратов, связанного с токсическим действием и угнетением микрофлоры кишечника, разработаны критерии ДСД. Эти критерии заключаются в установлении уровней, не действующих на макроорганизм (NOAEL, BMD), и минимальных ингибирующих концентраций для микроорганизмов. Анализ рекомендованных разработанных ДСД выявил, что ДСД многих ветеринарных препаратов определены с учётом лимитирующего критерия, однако из-за отсутствия методического подхода риск формирования антибиотикорезистентности при разработке ДСД не учитывался.</p><sec><title>Заключение</title><p>Заключение. Для установления ДСД и дальнейшего гигиенического нормирования необходимо исследовать все аспекты негативного действия ветеринарных препаратов с установлением отправных точек. Целесообразно обосновывать норматив на основе лимитирующего показателя вредности, выраженного в виде минимальной величины ДСД из всех критериев).</p></sec><sec><title>Участие авторов</title><p>Участие авторов: Зайцева Н.В. – концепция и дизайн исследования, написание текста; Шур П.З. – концепция и дизайн исследования, анализ и интерпретация результатов, написание текста; Зеленкин С.Е., Суворов Д.В. – концепция и дизайн исследования, сбор данных, анализ и интерпретация результатов, написание текста. Все соавторы – утверждение окончательного варианта статьи, ответственность за целостность всех частей статьи.</p></sec><sec><title>Конфликт интересов</title><p>Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p></sec><sec><title>Финансирование</title><p>Финансирование. Исследование не имело финансовой поддержки.</p></sec><sec><title>Поступила</title><p>Поступила: 19.02.2025 / Поступила после доработки: 17.03.2025 / Принята к печати: 26.03.2025 / Опубликована: 27.06.2025</p></sec></abstract><trans-abstract xml:lang="en"><p>The widespread use of antibacterial veterinary drugs in agriculture and animal husbandry leads to the accumulation of their residues in food products. Hygienic rationing of veterinary drug residues according to the criteria of acceptable health risk is a key aspect of food safety. Antibacterial drugs have an adverse toxic effect, cause disturbances in the gut microbiota, and contribute to the formation of antibiotic resistance. A systematic review of the criteria used to establish acceptable daily intakes (ADI) of veterinary drugs as the basis for the development of maximum permissible levels of their content in food – is relevant.</p><p>Objective of the study is the analysis of existing methodological approaches and criteria for justification of hygienic standards of residues of antibacterial veterinary drugs in food products.</p><p>A systematic review of literature sources (PRISMA) was carried out to evaluate approaches to the establishment of ADI, considering toxicological and microbiological aspects, as well as the formation of resistant strains of microorganisms. Criteria for establishing ADI have been developed for the adverse effects of veterinary drugs related to toxic effects and suppression of gut microflora. These criteria consist of establishing non-action levels on the macroorganism (NOAEL, BMD) and minimum inhibitory concentrations for microorganisms. Analysis of the recommended developed ADIs revealed many veterinary medicinal products ADIs to have been developed taking into account the limiting criterion. However, due to the lack of a methodological approach, the risk of antibiotic resistance formation was not taken into account in the development of ADIs.</p><sec><title>Conclusion</title><p>Conclusion. to establish ADI and further hygienic standardization, it is necessary to investigate all aspects of the advers effects of veterinary drugs with the establishment of starting points. It is advisable to justify the standard on the basis of the limiting indicator of harmfulness (expressed as the minimum value of the ADI of all criteria).</p></sec><sec><title>Contribution</title><p>Contribution: Zaitseva N.V. – study concept and design, writing text; Shur P.Z. – study concept and design, analysis and interpretation of results, writing text; Zelenkin S.E., Suvorov D.V. – study concept and design, data collection, analysis and interpretation of results, writing text. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.</p></sec><sec><title>Conflict of interest</title><p>Conflict of interest. The authors declare no conflict of interest.</p></sec><sec><title>Funding</title><p>Funding. The study had no sponsorship.</p></sec><sec><title>Received</title><p>Received: February 19, 2025 / Revised: March 17, 2025 / Accepted: March 26, 2025 / Published: June 27, 2025</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ветеринарные препараты</kwd><kwd>антибиотики</kwd><kwd>BMD</kwd><kwd>NOAEL</kwd><kwd>резистентность</kwd><kwd>MIC50</kwd><kwd>лимитирующий показатель вредности</kwd><kwd>систематический обзор</kwd></kwd-group><kwd-group xml:lang="en"><kwd>veterinary drugs</kwd><kwd>antibiotics</kwd><kwd>BMD</kwd><kwd>NOAEL</kwd><kwd>resistance</kwd><kwd>MIC50</kwd><kwd>limiting harmfulness indicator</kwd><kwd>systematic review</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Организация Объединенных наций. Цели в области устойчивого развития. Доступно: https://un.org/sustainabledevelopment/ru/sustainable-development-goals/</mixed-citation><mixed-citation xml:lang="en">United Nations. The Sustainable Development Goals. Available at: https://un.org/sustainabledevelopment/ru/sustainable-development-goals/ (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rafiq K., Tofazzal Hossain M., Ahmed R., Hasan M.M., Islam R., Hossen M.I., et al. Role of different growth enhancers as alternative to in-feed antibiotics in poultry industry. Front. Vet. Sci. 2022; 8: 794588. https://doi.org/10.3389/fvets.2021.794588</mixed-citation><mixed-citation xml:lang="en">Rafiq K., Tofazzal Hossain M., Ahmed R., Hasan M.M., Islam R., Hossen M.I., et al. Role of different growth enhancers as alternative to in-feed antibiotics in poultry industry. Front. Vet. Sci. 2022; 8: 794588. https://doi.org/10.3389/fvets.2021.794588</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Минаева Л.П., Шевелева С.А. Антибиотики в сельском хозяйстве как фактор формирования антимикробной резистентности и источник контаминации пищевой продукции. Успехи медицинской микологии. 2019; (20): 441–4. https://elibrary.ru/pcopkl</mixed-citation><mixed-citation xml:lang="en">Minaeva L.P., Sheveleva S.A. Antibiotics in agriculture as a factor in the formation of antimicrobial resistance and a source of food contamination. Uspekhi meditsinskoi mikologii. 2019; (20): 441–4. https://elibrary.ru/pcopkl (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Philpot W.N. Influence of subclinical mastitis on milk production and milk composition. J. Dairy Sci. 1967; 50(6): 978.</mixed-citation><mixed-citation xml:lang="en">Philpot W.N. Influence of subclinical mastitis on milk production and milk composition. J. Dairy Sci. 1967; 50(6): 978.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Jones G.M., Seymour E.H. Cowside antibiotic residue testing. J. Dairy Sci. 1988; 71(6): 1691–9. https://doi.org/10.3168/jds.S0022-0302(88)79734-9</mixed-citation><mixed-citation xml:lang="en">Jones G.M., Seymour E.H. Cowside antibiotic residue testing. J. Dairy Sci. 1988; 71(6): 1691–9. https://doi.org/10.3168/jds.S0022-0302(88)79734-9</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Dewdney J.M., Maes L., Raynaud J.P., Blanc F., Scheid J.P., Jackson T., et al. Risk assessment of antibiotic residues of beta-lactams and macrolides in food products with regard to their immuno-allergic potential. Food Chem. Toxicol. 1991; 29(7): 477–83. https://doi.org/10.1016/0278-6915(91)90095-o</mixed-citation><mixed-citation xml:lang="en">Dewdney J.M., Maes L., Raynaud J.P., Blanc F., Scheid J.P., Jackson T., et al. Risk assessment of antibiotic residues of beta-lactams and macrolides in food products with regard to their immuno-allergic potential. Food Chem. Toxicol. 1991; 29(7): 477–83. https://doi.org/10.1016/0278-6915(91)90095-o</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dayan A.D. Allergy to antimicrobial residues in food: assessment of the risk to man. Vet. Microbiol. 1993; 35(3–4): 213–26. https://doi.org/10.1016/0378-1135(93)90146-x</mixed-citation><mixed-citation xml:lang="en">Dayan A.D. Allergy to antimicrobial residues in food: assessment of the risk to man. Vet. Microbiol. 1993; 35(3–4): 213–26. https://doi.org/10.1016/0378-1135(93)90146-x</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Waltner-Toews D., McEwen S.A. Residues of antibacterial and antiparasitic drugs in foods of animal origin: a risk assessment. Prev. Vet. Med. 1994; 20(3): 219–34. https://doi.org/10.1016/0167-5877(94)90084-1</mixed-citation><mixed-citation xml:lang="en">Waltner-Toews D., McEwen S.A. Residues of antibacterial and antiparasitic drugs in foods of animal origin: a risk assessment. Prev. Vet. Med. 1994; 20(3): 219–34. https://doi.org/10.1016/0167-5877(94)90084-1</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Granowitz E.V., Brown R.B. Antibiotic adverse reactions and drug interactions. Crit. Care Clin. 2008; 24(2): 421–42, xi. https://doi.org/10.1016/j.ccc.2007.12.011</mixed-citation><mixed-citation xml:lang="en">Granowitz E.V., Brown R.B. Antibiotic adverse reactions and drug interactions. Crit. Care Clin. 2008; 24(2): 421–42, xi. https://doi.org/10.1016/j.ccc.2007.12.011</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Padol A.R., Malapure C.D., Domple V.D., Kamdi B.P. Occurrence, public health implications and detection of antibacterial drug residues in cow milk. Environ. We Int. J. Sci. Tech. 2015; 10(2015): 7–28.</mixed-citation><mixed-citation xml:lang="en">Padol A.R., Malapure C.D., Domple V.D., Kamdi B.P. Occurrence, public health implications and detection of antibacterial drug residues in cow milk. Environ. We Int. J. Sci. Tech. 2015; 10(2015): 7–28.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gutierrez A., Elez M., Clermont O., Denamur E., Matic I. Escherichia coli YafP protein modulates DNA damaging property of the nitroaromatic compounds. Nucleic Acids Res. 2011; 39(10): 4192–201. https://doi.org/10.1093/nar/gkr050</mixed-citation><mixed-citation xml:lang="en">Gutierrez A., Elez M., Clermont O., Denamur E., Matic I. Escherichia coli YafP protein modulates DNA damaging property of the nitroaromatic compounds. Nucleic Acids Res. 2011; 39(10): 4192–201. https://doi.org/10.1093/nar/gkr050</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Etminan M., Forooghian F., Brophy J.M., Bird S.T., Maberley D. Oral fluoroquinolones and the risk of retinal detachment. JAMA. 2012; 307(13): 1414–9. https://doi.org/10.1001/jama.2012.383</mixed-citation><mixed-citation xml:lang="en">Etminan M., Forooghian F., Brophy J.M., Bird S.T., Maberley D. Oral fluoroquinolones and the risk of retinal detachment. JAMA. 2012; 307(13): 1414–9. https://doi.org/10.1001/jama.2012.383</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ma F., Xu S., Tang Z., Li Z., Zhang L. Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans. Biosafety and Health. 2021; 3(1): 32–8. https://doi.org/10.1016/j.bsheal.2020.09.004</mixed-citation><mixed-citation xml:lang="en">Ma F., Xu S., Tang Z., Li Z., Zhang L. Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans. Biosafety and Health. 2021; 3(1): 32–8. https://doi.org/10.1016/j.bsheal.2020.09.004</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Шульга Н.Н., Шульга И.С., Плавшак Л.П. К проблеме антибиотиков в продуктах животноводства. Дальневосточный аграрный вестник. 2017; (4): 150–6. https://elibrary.ru/yqxndl</mixed-citation><mixed-citation xml:lang="en">Shulga N.N., Shulga I.S., Plavshak L.P. Re: antibiotics in livestock products. Dal’nevostochnyi agrarnyi vestnik. 2017; (4): 150–6. https://elibrary.ru/yqxndl (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Boobis A., Cerniglia C., Chicoine A., Fattori V., Lipp M., Reuss R., et al. Characterizing chronic and acute health risks of residues of veterinary drugs in food: latest methodological developments by the joint FAO/WHO expert committee on food additives. Crit. Rev. Toxicol. 2017; 47(10): 885–99. https://doi.org/10.1080/10408444.2017.1340259</mixed-citation><mixed-citation xml:lang="en">Boobis A., Cerniglia C., Chicoine A., Fattori V., Lipp M., Reuss R., et al. Characterizing chronic and acute health risks of residues of veterinary drugs in food: latest methodological developments by the joint FAO/WHO expert committee on food additives. Crit. Rev. Toxicol. 2017; 47(10): 885–99. https://doi.org/10.1080/10408444.2017.1340259</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372: n71. https://doi.org/10.1136/bmj.n71</mixed-citation><mixed-citation xml:lang="en">Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372: n71. https://doi.org/10.1136/bmj.n71</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lee M.H., Lee H.J., Ryu P.D. Public health risks: Chemical and antibiotic residues – review. Asian Australas. J. Anim. Sci. 2001; 14(3): 402–13. https://doi.org/10.5713/ajas.2001.402</mixed-citation><mixed-citation xml:lang="en">Lee M.H., Lee H.J., Ryu P.D. Public health risks: Chemical and antibiotic residues – review. Asian Australas. J. Anim. Sci. 2001; 14(3): 402–13. https://doi.org/10.5713/ajas.2001.402</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Crump K.S. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 1984; 4(5): 854–71. https://doi.org/10.1016/0272-0590(84)90107-6</mixed-citation><mixed-citation xml:lang="en">Crump K.S. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 1984; 4(5): 854–71. https://doi.org/10.1016/0272-0590(84)90107-6</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hardy A., Benford D., Halldorsson T., Jeger M.J., Knutsen K.H., More S., et al. Update: use of the benchmark dose approach in risk assessment. EFSA J. 2017; 15(1): e04658. https://doi.org/10.2903/j.efsa.2017.4658</mixed-citation><mixed-citation xml:lang="en">Hardy A., Benford D., Halldorsson T., Jeger M.J., Knutsen K.H., More S., et al. Update: use of the benchmark dose approach in risk assessment. EFSA J. 2017; 15(1): e04658. https://doi.org/10.2903/j.efsa.2017.4658</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Gaylor D.W. The use of safety factors for controlling risk. J. Toxicol. Environ. Health. 1983; 11(3): 329–36. https://doi.org/10.1080/15287398309530346</mixed-citation><mixed-citation xml:lang="en">Gaylor D.W. The use of safety factors for controlling risk. J. Toxicol. Environ. Health. 1983; 11(3): 329–36. https://doi.org/10.1080/15287398309530346</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Kimmel C.A., Gaylor D.W. Issues in qualitative and quantitative risk analysis for developmental toxicology. Risk Anal. 1988; 8(1): 15–20. https://doi.org/10.1111/j.1539-6924.1988.tb01149.x</mixed-citation><mixed-citation xml:lang="en">Kimmel C.A., Gaylor D.W. Issues in qualitative and quantitative risk analysis for developmental toxicology. Risk Anal. 1988; 8(1): 15–20. https://doi.org/10.1111/j.1539-6924.1988.tb01149.x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Leisenring W., Ryan L. Statistical properties of the NOAEL. Regul. Toxicol. Pharmacol. 1992; 15(2 Pt. 1): 161–71. https://doi.org/10.1016/0273-2300(92)90047-d</mixed-citation><mixed-citation xml:lang="en">Leisenring W., Ryan L. Statistical properties of the NOAEL. Regul. Toxicol. Pharmacol. 1992; 15(2 Pt. 1): 161–71. https://doi.org/10.1016/0273-2300(92)90047-d</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Benchmark Dose Technical Guidance (EPA/100/R-12/001). Washington; 2012. Available at: https://epa.gov/risk/benchmark-dose-technical-guidance</mixed-citation><mixed-citation xml:lang="en">Benchmark Dose Technical Guidance (EPA/100/R-12/001). Washington; 2012. Available at: https://epa.gov/risk/benchmark-dose-technical-guidance</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Zaitseva N.V., Shur P.Z., Atiskova N.G., Kamaltdinov M.R. Methodological approaches to the verification of hygienic standards using health risk criteria. Health Risk Analysis. 2014; (3): 19–25. https://doi.org/10.21668/health.risk/2014.3.02.eng</mixed-citation><mixed-citation xml:lang="en">Zaitseva N.V., Shur P.Z., Atiskova N.G., Kamaltdinov M.R. Methodological approaches to the verification of hygienic standards using health risk criteria. Health Risk Analysis. 2014; (3): 19–25. https://doi.org/10.21668/health.risk/2014.3.02.eng</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">WHO Report Series, N888. Toxicology monograph. Available at: https://apps.who.int/iris/bitstream/10665/42182/1/WHO_TRS_888.pdf</mixed-citation><mixed-citation xml:lang="en">WHO Report Series, N888. Toxicology monograph. Available at: https://apps.who.int/iris/bitstream/10665/42182/1/WHO_TRS_888.pdf</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Yujie Ben, Min Hu, Xingyue Zhang, Shimin Wu, Ming Hung Wong, Mingyu Wang et.al. Efficient detection and assessment of human exposure to trace antibiotic residues in drinking water. Water Research. 2020; 175: 115699. https://doi.org/10.1016/j.watres.2020.115699</mixed-citation><mixed-citation xml:lang="en">Yujie Ben, Min Hu, Xingyue Zhang, Shimin Wu, Ming Hung Wong, Mingyu Wang et.al. Efficient detection and assessment of human exposure to trace antibiotic residues in drinking water. Water Research. 2020; 175: 115699. https://doi.org/10.1016/j.watres.2020.115699</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Nair R.S., Stevens M.W., Martens M.A., Ekuta J. Comparison of BMD with NOAEL and LOAEL values derived from subchronic toxicity studies. Arch. Toxicol. Suppl. 1995; 17: 44–54. https://doi.org/10.1007/978-3-642-79451-3_5</mixed-citation><mixed-citation xml:lang="en">Nair R.S., Stevens M.W., Martens M.A., Ekuta J. Comparison of BMD with NOAEL and LOAEL values derived from subchronic toxicity studies. Arch. Toxicol. Suppl. 1995; 17: 44–54. https://doi.org/10.1007/978-3-642-79451-3_5</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI. (GL-36). Belgium; 2012.</mixed-citation><mixed-citation xml:lang="en">Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to establish a microbiological ADI. (GL-36). Belgium; 2012.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Silley P. Impact of antimicrobial residues on gut communities: are the new regulations effective? J. Appl. Microbiol. 2007; 102(5): 1220–6. https://doi.org/10.1111/j.1365-2672.2007.03288.x</mixed-citation><mixed-citation xml:lang="en">Silley P. Impact of antimicrobial residues on gut communities: are the new regulations effective? J. Appl. Microbiol. 2007; 102(5): 1220–6. https://doi.org/10.1111/j.1365-2672.2007.03288.x</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Food and Agriculture Organization/World Health Organization (FAO/WHO). Dose–response assessment and derivation of health-based guidance values. In: World Health Organization &amp; Food and Agriculture Organization of the United Nations, Principles and methods for the risk assessment of chemicals in food. 2020; (5–1): 5–115. Available at: https://cdn.who.int/media/docs/default-source/food-safety/publications/chapter5-dose-response.pdf?sfvrsn=32edc2c6_5</mixed-citation><mixed-citation xml:lang="en">Food and Agriculture Organization/World Health Organization (FAO/WHO). Dose–response assessment and derivation of health-based guidance values. In: World Health Organization &amp; Food and Agriculture Organization of the United Nations, Principles and methods for the risk assessment of chemicals in food. 2020; (5–1): 5–115. Available at: https://cdn.who.int/media/docs/default-source/food-safety/publications/chapter5-dose-response.pdf?sfvrsn=32edc2c6_5</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Онищенко Г.Г., Шевелева С.А., Хотимченко С.А. Гигиеническое обоснование допустимых уровней антибиотиков тетрациклиновой группы в пищевой продукции. Гигиена и санитария. 2012; 91(6): 4–14. https://elibrary.ru/pwktgr</mixed-citation><mixed-citation xml:lang="en">Onishchenko G.G., Sheveleva S.A., Khotimchenko S.A. Hygienic substantiation of the permissible levels for tetracycline-group antibiotics in food. Gigiena i Sanitaria (Hygiene and Sanitation, Russian journal). 2012; 91(6): 4–14. https://elibrary.ru/pwktgr (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Nouws J.F., Kuiper H., van Klingeren B., Kruyswijk P.G. Establishment of a microbiologically acceptable daily intake of antimicrobial drug residues. Vet. Q. 1994; 16(3): 152–6. https://doi.org/10.1080/01652176.1994.9694439</mixed-citation><mixed-citation xml:lang="en">Nouws J.F., Kuiper H., van Klingeren B., Kruyswijk P.G. Establishment of a microbiologically acceptable daily intake of antimicrobial drug residues. Vet. Q. 1994; 16(3): 152–6. https://doi.org/10.1080/01652176.1994.9694439</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Guidance document for the establishment of Acute Reference Dose (ARfD) for veterinary drug residues in food. Joint FAO/WHO Expert Committee on Food Additives (JECFA). World Health Organization and Food and Agriculture Organization of the United Nations; 2017.</mixed-citation><mixed-citation xml:lang="en">Guidance document for the establishment of Acute Reference Dose (ARfD) for veterinary drug residues in food. Joint FAO/WHO Expert Committee on Food Additives (JECFA). World Health Organization and Food and Agriculture Organization of the United Nations; 2017.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Сперанская В.Г., Федоренко Е.В. Вопросы нормирования антибактериальных препаратов в пищевой продукции. В кн.: Здоровье и окружающая среда: сборник материалов международной научно-практической конференции. Минск; 2018: 30–3. https://elibrary.ru/yuubwp</mixed-citation><mixed-citation xml:lang="en">Speranskaya V.G., Fedorenko E.V. Issues of rationing of antibacterials in food products. In: Health and Environment: Collection of Materials of the International Scientific and Practical Conference [Zdorov’e i okruzhayushchaya sreda: sbornik materialov mezhdunarodnoi nauchno-prakticheskoi konferentsii]. Minsk; 2018: 30–3. https://elibrary.ru/yuubwp (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Cerniglia C.E., Pineiro S.A., Kotarski S.F. An update discussion on the current assessment of the safety of veterinary antimicrobial drug residues in food with regard to their impact on the human intestinal microbiome. Drug Test. Anal. 2016; 8(5–6): 539–48. https://doi.org/10.1002/dta.2024</mixed-citation><mixed-citation xml:lang="en">Cerniglia C.E., Pineiro S.A., Kotarski S.F. An update discussion on the current assessment of the safety of veterinary antimicrobial drug residues in food with regard to their impact on the human intestinal microbiome. Drug Test. Anal. 2016; 8(5–6): 539–48. https://doi.org/10.1002/dta.2024</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Ben Y., Hu M., Zhang X., Wu S., Wong M.H., Wang M., et al. Efficient detection and assessment of human exposure to trace antibiotic residues in drinking water. Water Res. 2020; 175: 115699. https://doi.org/10.1016/j.watres.2020.115699</mixed-citation><mixed-citation xml:lang="en">Ben Y., Hu M., Zhang X., Wu S., Wong M.H., Wang M., et al. Efficient detection and assessment of human exposure to trace antibiotic residues in drinking water. Water Res. 2020; 175: 115699. https://doi.org/10.1016/j.watres.2020.115699</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Guideline on the approach to establish a pharmacological ADI. European Medicines Agency (EMA). Available at: https://preview-assets-us-01.kc-usercontent.com/49d837e7-4c3e-0071-59f0-cb4344fbf121/d8905e80-f226-4d53-b9f1-f5cde1e2cf6d/WC500120832.pdf</mixed-citation><mixed-citation xml:lang="en">Guideline on the approach to establish a pharmacological ADI. European Medicines Agency (EMA). Available at: https://preview-assets-us-01.kc-usercontent.com/49d837e7-4c3e-0071-59f0-cb4344fbf121/d8905e80-f226-4d53-b9f1-f5cde1e2cf6d/WC500120832.pdf</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Шевелева С.А., Хотимченко С.А., Минаева Л.П., Смотрина Ю.В. Минорные количества антибиотиков в пищевых продуктах: в чем риски для потребителей. Вопросы питания. 2021; 90(3): 50–7. https://doi.org/10.33029/0042-8833-2021-90-3-50-57 https://elibrary.ru/jkycga</mixed-citation><mixed-citation xml:lang="en">Sheveleva S.A., Khotimchenko S.A., Minaeva L.P., Smotrina Yu.V. Minor antibiotics residues in food: what are the risks for consumers. Voprosy pitaniya. 2021; 90(3): 50–7. https://doi.org/10.33029/0042-8833-2021-90-3-50-57 https://elibrary.ru/jkycga (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Admassie M. Current review on molecular and phenotypic mechanism of bacterial resistance to antibiotic. Sci. J. Clin. Med. 2018; 7(2): 13–9. https://doi.org/10.11648/j.sjcm.20180702.11</mixed-citation><mixed-citation xml:lang="en">Admassie M. Current review on molecular and phenotypic mechanism of bacterial resistance to antibiotic. Sci. J. Clin. Med. 2018; 7(2): 13–9. https://doi.org/10.11648/j.sjcm.20180702.11</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Chereau F., Opatowski L., Tourdjman M., Vong S. Risk assessment for antibiotic resistance in South East Asia. BMJ. 2017; 358: j3393. https://doi.org/10.1136/bmj.j3393</mixed-citation><mixed-citation xml:lang="en">Chereau F., Opatowski L., Tourdjman M., Vong S. Risk assessment for antibiotic resistance in South East Asia. BMJ. 2017; 358: j3393. https://doi.org/10.1136/bmj.j3393</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Ben Y., Fu C., Hu M., Liu L., Wong M.H., Zheng C. Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review. Environ. Res. 2019; 169: 483–93. https://doi.org/10.1016/j.envres.2018.11.040</mixed-citation><mixed-citation xml:lang="en">Ben Y., Fu C., Hu M., Liu L., Wong M.H., Zheng C. Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review. Environ. Res. 2019; 169: 483–93. https://doi.org/10.1016/j.envres.2018.11.040</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Niegowska M., Wögerbauer M. Improving the risk assessment of antimicrobial resistance (AMR) along the food/feed chain and from environmental reservoirs using qMRA and probabilistic modelling. EFSA J. 2022; 20(Suppl. 1): e200407. https://doi.org/10.2903/j.efsa.2022.e200407</mixed-citation><mixed-citation xml:lang="en">Niegowska M., Wögerbauer M. Improving the risk assessment of antimicrobial resistance (AMR) along the food/feed chain and from environmental reservoirs using qMRA and probabilistic modelling. EFSA J. 2022; 20(Suppl. 1): e200407. https://doi.org/10.2903/j.efsa.2022.e200407</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Klein E.Y., Tseng K.K., Pant S., Laxminarayan R. Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index. BMJ Glob. Health. 2019; 4(2): e001315. https://doi.org/10.1136/bmjgh-2018-001315</mixed-citation><mixed-citation xml:lang="en">Klein E.Y., Tseng K.K., Pant S., Laxminarayan R. Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index. BMJ Glob. Health. 2019; 4(2): e001315. https://doi.org/10.1136/bmjgh-2018-001315</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Li X., Liang B., Xu D., Wu C., Li J., Zheng Y. Antimicrobial resistance risk assessment models and database system for animal-derived pathogens. Antibiotics (Basel). 2020; 9(11): 829. https://doi.org/10.3390/antibiotics9110829</mixed-citation><mixed-citation xml:lang="en">Li X., Liang B., Xu D., Wu C., Li J., Zheng Y. Antimicrobial resistance risk assessment models and database system for animal-derived pathogens. Antibiotics (Basel). 2020; 9(11): 829. https://doi.org/10.3390/antibiotics9110829</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Vandenbroucke-Grauls C.M.J.E., Kahlmeter G., Kluytmans J., Kluytmans-van den Bergh M., Monnet D.L., Simonsen G.S., et al. The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance. BMJ Glob. Health. 2019; 4(4): e001838. https://doi.org/10.1136/bmjgh-2019-001838</mixed-citation><mixed-citation xml:lang="en">Vandenbroucke-Grauls C.M.J.E., Kahlmeter G., Kluytmans J., Kluytmans-van den Bergh M., Monnet D.L., Simonsen G.S., et al. The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance. BMJ Glob. Health. 2019; 4(4): e001838. https://doi.org/10.1136/bmjgh-2019-001838</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Zaitseva N.V., Shur P.Z., Atiskova N.G., Kiryanov D.A., Kamaltdinov M.R. Human health hazards associated with tetracycline drugs residues in food. Int. J. Adv. Res. 2014; 2(8): 488–95.</mixed-citation><mixed-citation xml:lang="en">Zaitseva N.V., Shur P.Z., Atiskova N.G., Kiryanov D.A., Kamaltdinov M.R. Human health hazards associated with tetracycline drugs residues in food. Int. J. Adv. Res. 2014; 2(8): 488–95.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Wouters M.F.A., van Koten-Vermeulen J.E.M., van Leeuwen F.X.R. Toxicity data for chlortetracycline and tetracycline; 2019. Available at: https://inchem.org/documents/jecfa/jecmono/v36je06.htm</mixed-citation><mixed-citation xml:lang="en">Wouters M.F.A., van Koten-Vermeulen J.E.M., van Leeuwen F.X.R. Toxicity data for chlortetracycline and tetracycline; 2019. Available at: https://inchem.org/documents/jecfa/jecmono/v36je06.htm</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
